Business Today
Subscribe
PMS TodayUnion BudgetUS NewsIndiaWeatherBT ShortsNRIEducationElection
BT GolfBT India 100BT Mindrush
Search
Advertisement
Business News
markets
stocks
Mankind Pharma Ltd
Mankind Pharma Ltd

Mankind Pharma Ltd (MANKIND) Share Price

  • Sector: Pharmaceuticals (Mid Cap)
  • Volume: 2,61,324
Jan 14, 2026
  • NSE
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹2,244.40
₹30.50 (1.38%)
2,207.10Low
Today’s Performance
2,252.20High
2,090.00Low
52 Week’s Performance
2,754.70High

bt_logoStock Analysis

bt_logoStock Performance

  • 1 Day1.38%
  • 1 Week-1.20%
  • 1 Month3.40%
  • 3 Months-9.36%
  • 6 Months-17.90%
  • 1 Year-14.72%
  • 3 Years15.89%
  • 5 Years-%

bt_logoStock Summary

  • Face Value (₹)1.00
  • Beta0.67
  • 52-Week Low (₹)2,090.00
  • 52-Week High (₹)2,754.70
  • Price-to-Book (X)*5.98
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*51.50
  • Earnings Per Share (₹)42.97
  • Market Cap (₹ Cr.)*91,390.91
* Values as of last close price

bt_logoCOMPETITORS

BT TV

Sugar Crisis Deepens As ISMA Director Deepak Ballani Flags MSP Hike And Ethanol Policy Risks6:58Sugar Crisis Deepens As ISMA Director Deepak Ballani Flags MSP Hike And Ethanol Policy Risks
Silver ETFs Hit Record Highs: Is This Rally Sustainable or a Crash Waiting?2:35Silver ETFs Hit Record Highs: Is This Rally Sustainable Or A Crash Waiting?
BJP Faces Political Firestorm After Hosting Chinese Communist Party Delegation Amid Shaksgam Valley Tensions3:54BJP Faces Political Firestorm After Hosting CCP Delegation Amid Shaksgam Valley Tensions
“Want To Build Cars In US, Not In Canada”: Trump Says Tariffs Pushed Automakers To Shift Production2:20“Want To Build Cars In US, Not In Canada”: Trump Says Tariffs Pushed Automakers To Shift Production
Centre Steps In to Protect Gig Workers as Quick Commerce Firms Asked to Drop Risky 10-Minute Delivery Promises3:05Centre Steps In To Protect Gig Workers As Quick Commerce Firms Asked To Drop 10-Min Delivery Promise
Trump’s Iran 25% Tariff Threat Raises Fresh Risks For India’s Trade2:29Trump’s Iran 25% Tariff Threat Raises Fresh Risks For India’s Trade
Iran Tariff Warning: Ajai Sahai Says India Safe, Trade Talks With US Give Hope7:53Iran Tariff Warning: Ajay Sahai Says India Safe, Trade Talks With US Give Hope
Indonesia Eyes Pakistan’s JF-17 As Defence Talks Intensify3:08Indonesia Eyes Pakistan’s JF-17 As Defence Talks Intensify
Iran Crisis Hits Rice Prices: ₹2,000 Crore Of Indian Export Payments At Risk8:15Iran Crisis Hits Rice Prices: ₹2,000 Crore Of Indian Export Payments At Risk
Union Budget 2026: After Tax Cuts, What Next? Decoding Budget Expectations4:22Union Budget 2026: After Tax Cuts, What Next? Decoding Budget Expectations
View more

bt_logoFAQ's

What was Mankind Pharma Ltd share price previously?
Mankind Pharma Ltd share price was up by 1.38% from the previous closing price of ₹2,213.90.
Who are peers of Mankind Pharma Ltd?
The peers of Mankind Pharma Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Cipla Ltd, Lupin Ltd, Dr Reddys Laboratories Ltd, Zydus Lifesciences Ltd.
Who is/are the promoter/promoters of Mankind Pharma Ltd?
The promotor/promotors of Mankind Pharma Ltd are RAMESH CHAND JUNEJA, RAJEEV JUNEJA, SHEETAL ARORA, TILOKCHAND PUNAMCHAND OSTWAL, Bharat Anand, SATISH KUMAR SHARMA, Vivek Kalra, Vijaya Sampath, Hitesh Kumar Jain.
What has been 52-week high of Mankind Pharma Ltd stocks?
The highest price of Mankind Pharma Ltd stock is ₹2,754.70 in the last 52-week.
What is the share price of Mankind Pharma Ltd (MANKIND) today on NSE?
As on Jan 14, 2026 Mankind Pharma Ltd (MANKIND)’s share price on NSE is Rs 2244.4
What is the market cap of Mankind Pharma Ltd (MANKIND)?
The current market capitalisation of Mankind Pharma Ltd (MANKIND) is 91,390.91 crores
What is Mankind Pharma Ltd Share symbol?
The symbol of Mankind Pharma Ltd is MANKIND.
What is the PE ratio of Mankind Pharma Ltd (MANKIND)?
The current PE ratio of Mankind Pharma Ltd (MANKIND) is 51.50.
What is the PB ratio of Mankind Pharma Ltd (MANKIND)?
The current PB ratio of Mankind Pharma Ltd (MANKIND) is 5.98.
Today’s High & Low share prices of Mankind Pharma Ltd (MANKIND) on NSE?
Today, the share price of Mankind Pharma Ltd (MANKIND) on NSE touched a high of Rs 2252.2 and a low of Rs 2207.1
What price did Mankind Pharma Ltd (MANKIND) shares open on the NSE today?
On NSE, the share price of Mankind Pharma Ltd (MANKIND) opened at Rs 2224
What is the 52-week high of Mankind Pharma Ltd (MANKIND)?
The 52-week high price of Mankind Pharma Ltd (MANKIND) is Rs 2,754.70
What is the 52-week low of Mankind Pharma Ltd (MANKIND)?
The 52-week low price of Mankind Pharma Ltd (MANKIND) is Rs 2,090.00

bt_logoAbout Mankind Pharma

Mankind Pharma Ltd, incorporated in the year 1991, has its registered office in 208 Okhla Industrial Estate, Phase-III, New Delhi, New Delhi, 110020, 91-11-47476600. The main industry in which Mankind Pharma Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Mankind Pharma Ltd is/are S R Batliboi & Co LLP/Bhagi Bhardwaj Gaur & Co. In the main management, RAMESH CHAND JUNEJA is chairman and Hitesh Kumar Jain is the company secretary for Mankind Pharma Ltd.

  • RCJ
    RAMESH CHAND JUNEJAChairman & Wholetime Director
  • RJ
    RAJEEV JUNEJAVice Chairman & Managing Director
  • SA
    SHEETAL ARORAWhole Time Director & Chief Executive Officer
  • TPO
    TILOKCHAND PUNAMCHAND OSTWALIndependent Director
  • BA
    Bharat AnandIndependent Director
  • SKS
    SATISH KUMAR SHARMAWhole-time Director
  • VK
    Vivek KalraIndependent Director
  • VS
    Vijaya SampathIndependent Director
  • HKJ
    Hitesh Kumar JainCompany Sec. & Compli. Officer

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.